The Utilization Pattern and Costs Analysis of Psychotropic Drugs at a Neuropsychiatric Hospital in Nigeria

Ezenduka, Charles

doi:10.9734/bjpr/2014/5988

Cited by 16 publications

(16 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A lack of training of health-care professionals in a number of LMICs, the stigma associated with mental disorders exacerbated by preconceptions and cultural issues as well as a lack of clear referral systems and support to treat mental disorders, all negatively impact on care provision alongside concerns with access to care and appropriate treatment [3,4,12,16,23,[37][38][39][40][41][42][43][44][45][46][47][48][49]. There is also considerable use of traditional medicines and faith healers in a number of LMICs which may also have a negative impact on patient outcomes; however, this may not always be the case [50][51][52].…”

Section: Generalmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Godman

Grobler

Van-De-Lisle

et al. 2019

Expert Opinion on Pharmacotherapy

View full text Add to dashboard Cite

Introduction: Appropriately managing mental disorders is a growing priority across countries in view of the impact on morbidity and mortality. This includes patients with bipolar disorders (BD). Management of BD is a concern as this is a complex disease with often misdiagnosis, which is a major issue in lower and middleincome countries (LMICs) with typically a limited number of trained personnel and resources. This needs to be addressed. Areas covered: Medicines are the cornerstone of managing patients with Bipolar II across countries including LMICs. The choice of medicines, especially antipsychotics, is important in LMICs with high rates of diabetes and HIV. However, care is currently compromised in LMICs by issues such as the stigma, cultural beliefs, a limited number of trained professionals and high patient co-payments. Expert opinion: Encouragingly, some LMICs have introduced guidelines for patients with BD; however, this is very variable. Strategies for the future include addressing the lack of national guidelines for patients with BD, improving resources for mental disorders including personnel, improving medicine availability and patients' rights, and monitoring prescribing against agreed guidelines. A number of strategies have been identified to improve the treatment of patients with Bipolar II in LMICs, and will be followed up.

show abstract

Section: Generalmentioning

confidence: 99%

“…• Issues of polypharmacy and adherence remain as additional critical concerns in the effective management of BD in Nigeria alongside copayments [39,139,176,177].…”

Section: Nigeriamentioning

confidence: 99%

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Godman

Grobler

Van-De-Lisle

et al. 2019

Expert Opinion on Pharmacotherapy

View full text Add to dashboard Cite

show abstract

“…All others are bought by patients (OOP) if they do not have access to health insurance. However, high patient co-payments potentially impact on available medicine choices as well as affecting long term compliance [29,30].…”

Section: Introductionmentioning

confidence: 99%

Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future

et al. 2016

View full text Add to dashboard Cite

This version is available at https://strathprints.strath.ac.uk/54803/ Strathprints is designed to allow users to access the research output of the University of Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights for the papers on this site are retained by the individual authors and/or other copyright owners. Please check the manuscript for details of any other licences that may have been applied. You may not engage in further distribution of the material for any profitmaking activities or any commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the content of this paper for research or private study, educational, or not-for-profit purposes without prior permission or charge.Any correspondence concerning this service should be sent to the Strathprints administrator: strathprints@strath.ac.ukThe Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the management and persistent access to Strathclyde's intellectual output. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than 1 defined daily dose in the majority, with high use of originators.

show abstract

“…higher than the value, 2.6 reported 3.3 by Adibe et al (2009), in south-east Nigeria [18] , Jimoh et al (2011) in north-west Nigeria [19] and similar to 4 drugs reported by Bnouham et al (2006) in southwest Nigeria [20] . The WHO recommended 2-3 drugs per prescription for developing countries [21] , suggesting a tendency for poly-pharmacy in this study. Many of the prescriptions recorded up to 5 to 6 drugs per prescription, thereby increasing the risks of drug related problems and reduced quality of life of patients.…”

Section: Co-morbiditymentioning

confidence: 68%

A Study of Drug Use in Type 2 Diabetes Mellitus with and Without CoMorbidities in Patients Visiting A Tertiary Care Hospital

Patil¹

2017

jmscr

View full text Add to dashboard Cite

The Utilization Pattern and Costs Analysis of Psychotropic Drugs at a Neuropsychiatric Hospital in Nigeria

Cited by 16 publications

References 17 publications

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future

A Study of Drug Use in Type 2 Diabetes Mellitus with and Without CoMorbidities in Patients Visiting A Tertiary Care Hospital

Contact Info

Product

Resources

About